The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 07, 2025

Filed:

Jun. 27, 2018
Applicants:

Agency for Science, Technology and Research, Singapore, SG;

Lion Tcr Pte. Ltd., Singapore, SG;

Inventors:

Ernest Guccione, Singapore, SG;

Dave Keng Boon Wee, Singapore, SG;

Antonio Bertoletti, Singapore, SG;

Assignees:
Attorney:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); A61K 31/7088 (2006.01); A61K 35/17 (2015.01); A61P 35/00 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12N 15/113 (2013.01); A61K 31/7088 (2013.01); A61K 35/17 (2013.01); A61P 35/00 (2018.01); C12N 15/1136 (2013.01); C12N 15/1138 (2013.01); C12N 2310/11 (2013.01); C12N 2310/351 (2013.01); C12N 2320/33 (2013.01);
Abstract

The present invention relates to antisense oligonucleotides for modulating the function of a T cell, including antisense oligonucleotides that hybridise to IFN-γ, granzyme, perforin 1, PD-1, PRDM1, PD-L1, CD40LG, NDFIP1, PDCD1 LG2, REL, BTLA, CD80, CD160, CD244, LAG3, TIGIT, ADORA2A & TIM-3 RNAs. In particular, the present invention relates to antisense oligonucleotides capable of inducing exon skipping of RNA. Also claimed is a method for further modifying the specificity of said T-cell by providing for a T cell receptor gene.


Find Patent Forward Citations

Loading…